• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《老年人中高价肺炎球菌结合疫苗与13价肺炎球菌结合疫苗的免疫原性和安全性：随机对照试验的系统评价和荟萃分析》的勘误

Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

出版信息

Open Forum Infect Dis. 2025 Mar 20;12(3):ofaf169. doi: 10.1093/ofid/ofaf169. eCollection 2025 Mar.

DOI:10.1093/ofid/ofaf169
PMID:40114974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11925215/
Abstract

[This corrects the article DOI: 10.1093/ofid/ofae496.].

摘要

[本文更正了文章的数字对象标识符：10.1093/ofid/ofae496。]

相似文献

1
Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.对《老年人中高价肺炎球菌结合疫苗与13价肺炎球菌结合疫苗的免疫原性和安全性：随机对照试验的系统评价和荟萃分析》的勘误
Open Forum Infect Dis. 2025 Mar 20;12(3):ofaf169. doi: 10.1093/ofid/ofaf169. eCollection 2025 Mar.
2
Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.老年人群中高剂量肺炎球菌结合疫苗与13价肺炎球菌结合疫苗的免疫原性及安全性：随机对照试验的系统评价与荟萃分析
Open Forum Infect Dis. 2025 Feb 5;12(2):ofaf069. doi: 10.1093/ofid/ofaf069. eCollection 2025 Feb.
3
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis.13 价肺炎球菌结合疫苗在婴儿中的安全性和免疫原性：荟萃分析。
Vaccine. 2013 Nov 4;31(46):5349-58. doi: 10.1016/j.vaccine.2013.09.008. Epub 2013 Sep 19.
4
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis.免疫原性和安全性的 13 价肺炎球菌结合疫苗与 23 价肺炎球菌多糖疫苗在免疫功能正常的成年人：系统评价和荟萃分析。
Vaccine. 2019 Feb 14;37(8):1021-1029. doi: 10.1016/j.vaccine.2019.01.014. Epub 2019 Jan 23.
5
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.在未接种过肺炎球菌疫苗的成年人中，13价肺炎球菌结合疫苗与23价肺炎球菌多糖疫苗的免疫原性和安全性比较
Vaccine. 2013 Aug 2;31(35):3577-84. doi: 10.1016/j.vaccine.2013.04.085. Epub 2013 May 18.
6
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan.一项在日本、韩国和中国台湾地区≥60 岁成人中进行的 20 价肺炎球菌结合疫苗的安全性和免疫原性的 3 期随机试验。
Vaccine. 2024 Feb 15;42(5):1071-1077. doi: 10.1016/j.vaccine.2024.01.004. Epub 2024 Jan 23.
7
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.13价肺炎球菌结合疫苗在70岁及以上曾接种23价肺炎球菌多糖疫苗的成年人中的免疫原性和安全性。
Vaccine. 2013 Aug 2;31(35):3585-93. doi: 10.1016/j.vaccine.2013.05.010. Epub 2013 May 18.
8
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.15 价肺炎球菌结合疫苗在≥65 岁曾接种 23 价肺炎球菌多糖疫苗的成年人中的安全性和免疫原性与 13 价肺炎球菌结合疫苗比较。
Hum Vaccin Immunother. 2019;15(3):540-548. doi: 10.1080/21645515.2018.1532250. Epub 2018 Nov 14.
9
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.60 至 64 岁成人中 20 价肺炎球菌结合疫苗（PCV20）的安全性、耐受性和免疫原性。
Clin Infect Dis. 2021 Oct 5;73(7):e1489-e1497. doi: 10.1093/cid/ciaa1045.
10
Adult indication 13-valent pneumococcal conjugate vaccine clinical development overview: formulation, safety, immunogenicity (dosing and sequence), coadministration, and efficacy.成人适应证 13 价肺炎球菌结合疫苗临床开发概述：配方、安全性、免疫原性（剂量和顺序）、联合用药和疗效。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):944-957. doi: 10.1080/14760584.2024.2404636. Epub 2024 Sep 25.